---
figid: PMC11232665__ijmm-54-02-05395-g03
figtitle: Metformin likely acts on intervertebral disc degeneration through SIRT-related
  signalling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11232665
filename: ijmm-54-02-05395-g03.jpg
figlink: /pmc/articles/PMC11232665/figure/F4
number: F4
caption: Metformin likely acts on intervertebral disc degeneration through SIRT-related
  signalling pathways. Metformin reduces ADAMTs and MMPs by inhibiting the PI3K/Akt
  signaling pathway. Activation of AMPK by metformin reduces COX2 expression by activating
  the SIRT1 and activates the SIRT3 pathway on the other hand, thereby increasing
  PINK1, FOXO3, and mitochondrial activity, and consequently decreasing IL-1β and
  ROS levels. Figure adapted from Server Medical Art (https://smart.servier.com/).
  COX2, cyclooxygenase-2; PI3K, phosphoinositide 3-kinase; ROS, reactive oxygen species;
  SIRT, sirtuin; ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs;
  AMPK, AMP)-activated protein kinase; SOD, superoxide dismutase; PINK, PTEN) induced
  putative kinase
papertitle: 'Metformin prevents the onset and progression of intervertebral disc degeneration:
  New insights and potential mechanisms (Review)'
reftext: Wenzhi Yang, et al. Int J Mol Med. 2024 Aug;54(2).
year: '2024'
doi: 10.3892/ijmm.2024.5395
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: metformin | type 2 diabetes mellitus | intervertebral disc degeneration
  | nucleus pulposus | mechanism | treatment
automl_pathway: 0.9568324
figid_alias: PMC11232665__F4
figtype: Figure
redirect_from: /figures/PMC11232665__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11232665__ijmm-54-02-05395-g03.html
  '@type': Dataset
  description: Metformin likely acts on intervertebral disc degeneration through SIRT-related
    signalling pathways. Metformin reduces ADAMTs and MMPs by inhibiting the PI3K/Akt
    signaling pathway. Activation of AMPK by metformin reduces COX2 expression by
    activating the SIRT1 and activates the SIRT3 pathway on the other hand, thereby
    increasing PINK1, FOXO3, and mitochondrial activity, and consequently decreasing
    IL-1β and ROS levels. Figure adapted from Server Medical Art (https://smart.servier.com/).
    COX2, cyclooxygenase-2; PI3K, phosphoinositide 3-kinase; ROS, reactive oxygen
    species; SIRT, sirtuin; ADAMTS, a disintegrin and metalloproteinase with thrombospondin
    motifs; AMPK, AMP)-activated protein kinase; SOD, superoxide dismutase; PINK,
    PTEN) induced putative kinase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - IL1A
  - IL1B
  - AKT1
  - AKT2
  - AKT3
  - PPARGC1A
  - NFKB1
  - PTGS2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SIRT1
  - SIRT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - PINK1
  - SOD2
  - SOD2-OT1
  - MMP
  - PGC1
  - PGE2
  - Metformin
  - ROS
---
